Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of May 2019, with a specific reporting date of May 13, 2019. The document serves as a transaction notification regarding insider trading activities by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. It exclusively reports on specific share acquisition transactions.
| Transaction Date | Instrument | Price per Share | Total Volume | Exchange |
|---|---|---|---|---|
| 2019-05-10 | Ordinary Shares (25 pence each) | £15.1168 | 134 Shares (Aggregated) | London Stock Exchange (XLON) |
Note: The total volume of 134 shares is derived from the sum of individual transactions listed in the filing (18+16+16+16+18+16+18+16).
Material Changes
This filing does not report material changes to the company's financial position, operations, or strategy compared to prior periods. It is a routine disclosure of share acquisitions by senior executives and their associates.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The transactions were executed under the Company's Share Reward Plan, involving both partnership shares and matching shares.
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were acquisitions of ordinary shares under the Share Reward Plan, not open market sales or purchases.
- Participants: Transactions involved high-level executives including the CEO (Ms E Walmsley), President of Global Vaccines (Mr R G Connor), and other senior officers.
- Valuation: All shares were acquired at a uniform price of £15.1168 on May 10, 2019.
- Scope: The filing is limited to insider trading notifications and does not provide data on GSK's overall financial performance for the period.